Atlas Trials

Elafibranor, PK and Safety in Children and Adolescents 8 to 17 Years of Age With Non Alcoholic Steatohepatitis (NASH)

Clinical trial NCT03883607 · TERMINATED

Trial details

NCT number
NCT03883607
Sponsor
Genfit
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Non Alcoholic Steatohepatitis
Start date
2019-06-25
Primary completion
2020-06-16
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.